Moderna stock is trading sharply lower Monday afternoon as recent clinical setbacks overshadowed positive pipeline news.

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing ...

At $41.40, the average Moderna stock price target implies a 43.01% upside potential. See more MRNA analyst ratings.

Moderna is down 35.3% since the beginning of the year, and at $27.16 per share, it is trading 50.3% below its 52-week high of ...

Recently, Zacks.com users have been paying close attention to Moderna (MRNA). This makes it worthwhile to examine what the stock has in store.

Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their ...

According to TipRanks, Tenthoff is an analyst with an average return of -9.7% and a 36.01% success rate. Tenthoff covers the Healthcare sector, focusing on stocks such as Arvinas Holding Company, Skye ...

Major U.S. equities indexes mostly advanced Thursday as investors monitored China trade developments and digested the latest ...

Tesla’s stock was down 0.8% at the close, ahead of anticipated Q3 earnings, and continued to slide after the closing bell, ...